MAPKs Are Not Involved in Triptolide-Induced Cell Growth Inhibition and Apoptosis in Prostate Cancer Cell Lines with Different p53 Status

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Planta Medica

• Publication date

  2010-07-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-0030-1250076PMID 20607649
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor Immunology

  2018cited by this paper
• Curcumin‐induced apoptosis in ovarian carcinoma cells is p53‐independent and involves p38 mitogen‐activated protein kinase activation and downregulation of Bcl‐2 and survivin expression and Akt signaling

  2010cited by this paper
• 3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status.

  2009cited by this paper
• Signal integration by JNK and p38 MAPK pathways in cancer development

  2009cited by this paper
• Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer

  2009cited by this paper
• Phosphorylation of Bcl-2 and activation of caspase-3 via the c-Jun N-terminal kinase pathway in ursolic acid-induced DU145 cells apoptosis.

  2009cited by this paper
• eview ual specificity phosphatases in prostate cancer

  2009cited by this paper
• Desipramine-induced apoptosis in human PC3 prostate cancer cells: activation of JNK kinase and caspase-3 pathways and a protective role of [Ca2+]i elevation.

  2008cited by this paper
• WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.

  2008cited by this paper
• The power and promise of “rewiring” the mitogen-activated protein kinase network in prostate cancer therapeutics

  2007cited by this paper
• Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.

  2007cited by this paper
• AG490 influences UCN-01-induced cytotoxicity in glioma cells in a p53-dependent fashion, correlating with effects on BAX cleavage and BAD phosphorylation.

  2007cited by this paper
• [Effects of triptolide on prostate carcinoma in mouse RM-1 cells].

  2007cited by this paper
• Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation

  2007cited by this paper
• Prevalent mutations in prostate cancer

  2006cited by this paper
• Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models.

  2006cited by this paper
• Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.

  2006cited by this paper
• The functional Interactions Between the MAPK and p53 Signaling Pathways

  2004cited by this paper
• Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation.

  2004cited by this paper
• PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy.

  2003cited by this paper
• Triptolide inhibits the growth and metastasis of solid tumors.

  2003cited by this paper
• Androgen Receptor Acetylation Governs trans Activation and MEKK1-Induced Apoptosis without Affecting In Vitro Sumoylation and trans-Repression Function

  2002cited by this paper
• Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.

  2002cited by this paper
• Death and anti-death: tumour resistance to apoptosis

  2002cited by this paper
• Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-κB activation in gastric cancer cells

  2001cited by this paper
• Triptolide and Chemotherapy Cooperate in Tumor Cell Apoptosis

  2001cited by this paper
• Cancer cell lines

  1999cited by this paper
• The role of the p53 tumor suppressor gene in prostate cancer: a possible biomarker?

  1996cited by this paper
• Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents.

  1995cited by this paper
• p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.

  1993cited by this paper
• p53 oncogene mutations in three human prostate cancer cell lines

  1993cited by this paper
• Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing.

  1991cited by this paper

• Triptolide induces mitochondrial apoptosis through modulating dual specificity phosphatase 1/mitogen-activated protein kinases cascade in osteosarcoma cells.

  2018cites this paper
• Alteration of Androgen Receptor Protein Stability by Triptolide in LNCaP Cells

  2018cites this paper
• Triptolide, a HSP90 middle domain inhibitor, induces apoptosis in triple manner

  2018cites this paper
• Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F

  2015cites this paper
• Triptolide Synergistically Enhances Antitumor Activity of Oxaliplatin in Colon Carcinoma In Vitro and In Vivo

  2014cites this paper
• Triptolide induces apoptosis in endometrial cancer via a p53‑independent mitochondrial pathway.

  2014cites this paper
• Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells.

  2013cites this paper
• Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF.

  2013cites this paper
• Triptolide sensitizes TRAIL-induced apoptosis in prostate cancer cells via p53-mediated DR5 up-regulation

  2012cites this paper
• Triptolide Inhibits the Proliferation of Prostate Cancer Cells and Down-Regulates SUMO-Specific Protease 1 Expression

  2012cites this paper
• In vitro validation of multifunctional liposomes for leukaemia and prostate cancer therapy - the folate receptor and the prostate-specific membrane antigen as targets for drug delivery

  2012influential citation
• Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway.

  2011cites this paper